NMTC
NeuroOne Medical Technologies Corporation
NASDAQ · Healthcare · Medical - Devices · US
$1.62
−2.41%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 10.0M | 12.1M | 3.5M | 2.0M | 171.2K |
| Cost of Revenue | 4.4M | 4.0M | 2.4M | 1.5M | 242.0K |
| Gross Profit | 5.6M | 8.1M | 1.1M | 456.5K | (70.8K) |
| Operating Expenses | |||||
| R&D Expense | 5.4M | 5.0M | 5.1M | 6.9M | 4.9M |
| SG&A Expense | 7.8M | 7.4M | 7.9M | 6.9M | 7.0M |
| General & Admin Expense | 2.2M | — | 7.8M | 6.8M | 6.7M |
| Selling & Marketing Expense | — | — | 109.0K | 173.4K | 270.6K |
| Other Expenses | — | — | — | (1.5M) | (1.9M) |
| Total Operating Expenses | 13.2M | 12.4M | 13.0M | 12.4M | 10.0M |
| Cost and Expenses | 17.6M | 16.3M | 15.3M | 13.9M | 10.2M |
| Operating Income (EBIT) | (7.6M) | (4.2M) | (11.9M) | (12.0M) | (10.0M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | (334.1K) | 334.1K | 229.0K | — | — |
| Net Interest Income | 334.1K | (334.1K) | (229.0K) | — | — |
| Other Non-Op Income/Expense | 454.4K | 621.1K | (430.9K) | 95.8K | 31.2K |
| Non-Operating Income (excl Interest) | (454.4K) | (955.2K) | 201.9K | (95.8K) | (31.2K) |
| EBT (Pre-Tax Income) | (7.1M) | (3.6M) | (12.3M) | (11.9M) | (10.0M) |
| Income Tax Expense | — | — | — | — | — |
| Bottom Line | |||||
| Net Income | (7.1M) | (3.6M) | (12.3M) | (11.9M) | (10.0M) |
| Earnings from Cont. Ops | (7.1M) | (3.6M) | (12.3M) | (11.9M) | (10.0M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (7.1M) | (3.6M) | (12.3M) | (11.9M) | (10.0M) |
| Per Share | |||||
| Basic EPS | ($0.91) | ($0.54) | ($2.76) | ($3.90) | ($3.78) |
| Diluted EPS | ($0.96) | ($0.54) | ($2.76) | ($3.90) | ($3.78) |
| Revenue Per Share | $1.15 | $1.81 | $0.77 | $0.65 | $0.06 |
| Shares | |||||
| Basic Shares Outstanding | 8.7M | 6.7M | 4.5M | 3.0M | 2.7M |
| Diluted Shares Outstanding | 8.7M | 6.7M | 4.5M | 3.0M | 2.7M |
| Profitability Metrics | |||||
| EBITDA | (6.9M) | (3.0M) | (11.8M) | (11.7M) | (9.9M) |
| D&A | 236.9K | 261.7K | 246.8K | 199.3K | 118.6K |
| EBIT | (7.1M) | (3.3M) | (12.1M) | (11.9M) | (10.0M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026